panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
SSRIs showed no clear difference in number of dropouts due to adverse events compared with MAOIs (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
SSRIs showed no clear difference in failure to respond compared with SNRIs (high certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
SSRIs showed no clear difference in total number of dropouts compared with SNRIs (low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
SSRIs showed no clear difference in failure to remit compared with SNRIs (high certainty).
1 finding from 1 review
panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
SSRIs showed no clear difference in number of dropouts due to adverse effects compared with SNRIs (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
1 finding from 1 review
Leaving the study early · adults with panic disorder
SSRIs showed no clear difference in total number of dropouts compared with naSSAs (low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
1 finding from 1 review
panic symptoms · adults with panic disorder
1 finding from 1 review
Withdrawals due to adverse events · adults with panic disorder
SSRIs showed no clear difference in number of dropouts due to adverse events compared with naSSAs (low certainty).
1 finding from 1 review
Failure to respond at endpoint (6‐12 weeks) · adults with panic disorder
It is very uncertain whether TCAs changes failure to respond compared with benzodiazepines (very low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
It is very uncertain whether TCAs changes total number of dropouts compared with benzodiazepines (very low certainty).
1 finding from 1 review
Failure to remit at endpoint · adults with panic disorder
TCAs showed no clear difference in failure to remit compared with benzodiazepines (moderate certainty).
1 finding from 1 review
ADHD symptoms · Children and adolescents with ADHD
1 finding from 1 review
Depressive disorder according to DSM or ICD criteriaClinician diagnostic interview · patients with depressive disorders in children and adolescents
1 finding from 1 review
Suicide completionCompleted suicide rates · patients with depressive disorders in children and adolescents
1 finding from 1 review
Remission or response (as defined in trial) · patients with depressive disorders in children and adolescents
Second generation antidepressant probably leads to higher remission or response (as defined in trial) compared with placebo (by medication) (moderate certainty).
1 finding from 1 review
Suicide‐related outcomes Timing of outcome assessment: end of treatment (6 to 12 weeks treatment duration) · patients with depressive disorders in children and adolescents
Second generation antidepressant may leads to higher suicide‐related outcome compared with placebo (by medication) (low certainty).
1 finding from 1 review